Search

everythinglearnresearchcommunity

for

Search:↓

Certain groups of medications given when leaving the hospital are linked to a higher risk of negative drug reactions within 30 days, especially in older adults with respiratory issues.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Dexamethasone can cause diabetes in rats, and Annona muricata bark extract may help lower blood sugar.

A new score can help predict which patients might have trouble urinating after prostate surgery.

A fungal infection can look like a different scalp condition in teens, leading to wrong treatment until proper tests are done.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

FoxN1 gene is essential for proper thymus structure and preventing hair loss.

Finasteride causes lasting fertility decrease in rats.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

A more sensitive assay was developed to detect enzyme activity converting arginine to citrulline in hair follicles.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

Coats' Plus is a genetic disorder with eye abnormalities, brain calcification, poor growth, bone and skin issues, and movement disorders.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Finasteride helps hair growth but stopping it causes faster hair loss.

Argan oil and cupuassu butter can protect hair after dyeing.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

The document suggests fixing common hair transplant issues by combining artistic principles with plug reduction, recycling, and additional micrograft transplantation, while also potentially using arnica to help with post-operative swelling.

The document suggests that hair loss after stopping birth control may be similar to post-pregnancy hair loss and could recur with future pregnancies.

Post-COVID-19 patients are at risk for hair loss.

Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.

Ninjin'yoeito, a Japanese medicine, helped stop hair loss and improved mood in two post-COVID-19 patients.

Facial hair transplants are generally successful, with hair growth beginning around 3 months post-surgery.

Some people may naturally have beaded lines on their skin that are more visible with certain treatments, and hair loss similar to post-pregnancy can occur after specific diet and therapy.